Literature DB >> 29271052

Usefulness of hemostatic sealants for minimizing ovarian damage during laparoscopic cystectomy for endometriosis.

Chahien Choi1, Woo Young Kim1, Dong Hee Lee1, San Hui Lee2.   

Abstract

AIM: We aimed to evaluate the impact of topical hemostatic sealants and bipolar coagulation during laparoscopic ovarian endometriotic cyst resection on ovarian reserve by comparing the rates of decrease in anti-Müllerian hormone (AMH).
METHODS: A randomized prospective data collection was made on women aged 19-45 years who planned to have laparoscopic ovarian cystectomy at one of two institutions (n = 80), Kangbuk Samsung Hospital, Seoul, Korea or National Health Insurance Service Ilsan Hospital, Goyang, Korea, from January 2014 to April 2016. Patients were randomly divided into two groups treated with either a topical hemostatic sealant or bipolar coagulation for hemostasis. The hemostatic group was randomized to the FloSeal or TachoSil subgroups. Preoperative and 3-month postoperative AMH levels were checked and the rates of decrease of AMH were compared. All patients enrolled were treated with dienogest (Visanne) for 6-12 months. None were lost to follow-up at postoperative 3 months, but about one-third of the patients had been lost to follow-up by 6-12 months.
RESULTS: AMH was significantly decreased in both groups 3 months postoperatively; however, the rate of decrease in the bipolar coagulation group was greater than that in the hemostatic sealant group, 41.9% (interquartile range [IQR], 22.29-65.24) versus 18.1% (IQR, 10.94-29.90), P = 0.007. Between the two hemostatic subgroups, there was no significant difference in AMH decrease rate, 14.95% (IQR, 11.34-21.21) versus 18.1% (IQR 9.76-40.70), P = 0.204.
CONCLUSION: Hemostatic sealants may be an alternative to bipolar coagulation for preservation of ovarian reserve after laparoscopic ovarian cystectomy for endometriosis.
© 2017 Japan Society of Obstetrics and Gynecology.

Entities:  

Keywords:  anti-Müllerian hormone; endometriotic cyst; laparoscopic cystectomy; ovarian reserve; topical hemostatics

Mesh:

Substances:

Year:  2017        PMID: 29271052     DOI: 10.1111/jog.13542

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  5 in total

1.  Efficacy of ablation and sclerotherapy for the management of ovarian endometrioma: A narrative review.

Authors:  Byung Chul Jee
Journal:  Clin Exp Reprod Med       Date:  2022-05-04

2.  Systematic Review of Topical Hemostatic Agent Use in Minimally Invasive Gynecologic Surgery.

Authors:  Traci E Ito; Alexandra L Martin; Edith F Henderson; Jeremy T Gaskins; Vida M Vaughn; Shan M Biscette; Resad P Pasic
Journal:  JSLS       Date:  2018 Oct-Dec       Impact factor: 2.172

3.  A randomized controlled trial of ovarian reserve preservation and hemostasis during ovarian cystectomy.

Authors:  Soo Jin Park; Aeran Seol; Nara Lee; Seungmee Lee; Hee Seung Kim
Journal:  Sci Rep       Date:  2021-04-19       Impact factor: 4.379

Review 4.  The Effect of Laparoscopic Endometrioma Surgery on Anti-Müllerian Hormone: A Systematic Review of the Literature and Meta-Analysis.

Authors:  José Moreno-Sepulveda; Carolina Romeral; Geraldine Niño; Assumpció Pérez-Benavente
Journal:  JBRA Assist Reprod       Date:  2022-01-17

5.  Preservation of the ovarian reserve and hemostasis during laparoscopic ovarian cystectomy by a hemostatic agent versus suturing for patients with ovarian endometriosis: study protocol for randomized controlled, non-inferiority trial (PRAHA-2 trial).

Authors:  Hyunji Lim; Soo Jin Park; Haerin Paik; Jaehee Mun; Eun Ji Lee; Seungmee Lee; Whasun Lim; Gwonhwa Song; Seung-Hyuk Shim; Chae Hyeong Lee; Ga Won Yim; Hee Seung Kim
Journal:  Trials       Date:  2021-07-21       Impact factor: 2.279

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.